Dr. Alice D. Friedman, MD

Dr. Friedman practices at St David's North Austin Medical Center in Austin, Texas.

Dr. Friedman's NPI, 1306812359, was assigned on February 28, 2006. Dr. Friedman graduated from Texas A&M College of Medicine - Bryan in 1981. Dr. Friedman's Texas license number on file is F9451.

Dr. Friedman's primary practice is St David's North Austin Medical Center, at 12221 N Mopac Expy, Austin, TX 78758 in Travis County. The practice phone is (512) 901-1000.

Dr. Friedman's primary practice is St David's North Austin Medical Center in Austin, Texas. The medical group on file is Austin Diagnostic Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Friedman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Friedman's licenses on file in 7 states: Texas, Ohio, Virginia, Arkansas, Oklahoma, Maryland and Louisiana.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Friedman treats.

CMS data shows 440 Medicare services from Dr. Friedman across 12 procedure codes in 2024, for 215 Medicare patients. Medicare paid $37,382 for them.

CMS counts 215 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 68, with 72% women.

In 2024, Dr. Friedman wrote 1,684 Medicare Part D claims for 300 patients. 82% of them were for generic drugs. CMS names the drug for 1,539 of them, across 26 drugs with 11 or more claims each, at $1,245,686 in total drug cost. In 2023, CMS named 1,747 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group.

Dmand AI links 1 paper to Dr. Friedman. Dr. Friedman's most frequent co-authors are Sudhir K. Dutta, MD and Alan D. Friedman, MD.

Dmand AI links Dr. Friedman to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Abdominal Pain and Gastroparesis. Evoke Pharma sponsors the most, 2.

CMS Open Payments shows 564 general payments to Dr. Friedman from 40 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,812.

Dmand AI lists 3 awards for Dr. Friedman, most recently ACG Fellow in 2011.

Dr. Friedman graduated from Texas A&M College of Medicine - Bryan in 1981. Dr. Friedman is a member of ACG.

Dr. Friedman is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.